stonks4u
Sign up free
PROF logo

PROF Profound Medical Corp.

NASDAQ Capital Market · Medical - Devices · Healthcare

$6.63
-0.04 (-0.60%)

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the Uni…

Market Cap: $240.92Mwww.profoundmedical.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 14Aug 14

Quote

Day Range
$6.61 – $6.80
52-Week Range
$3.76 – $8.95
Volume
$99.8K
Market Cap
$240.92M
50-Day Avg
$7.01
200-Day Avg
$6.85
Prev Close
$6.67
Open
$6.64

Valuation & Ratios

P/E Ratio
-5.50
EPS
$-1.43
P/B Ratio
2.61
P/S Ratio
14.53
Debt/Equity
0.07
Current Ratio
12.52
Dividend Yield
+0.0%
Gross Margin
+70.8%

Returns & Efficiency

Return on Equity
-47.6%
Return on Assets
-22.4%
FCF Yield
-16.4%
EV/EBITDA
-3.93

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$16.38M$-43.32M$-1.43
2024$10.17M$-26.48M$-1.07
2023$7.20M$-28.57M$-1.35
2022$6.68M$-28.67M$-1.38
2021$6.87M$-30.70M$-1.50

Social Signal Score

50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
news: 1

Earnings

Thu, Nov 12(in 3 months)

Consensus estimate $-0.23 per share

4of 7 quarters beat consensus

Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$-0.26 vs $-0.22miss
  • Thu, May 7$-0.19 vs $-0.24beat
  • Thu, Mar 5$-0.27 vs $-0.27beat
  • Thu, Nov 13$-0.26 vs $-0.38beat
  • Thu, Aug 14$-0.52 vs $-0.43miss
  • Thu, May 8$-0.36 vs $-0.29miss

Estimates and results for PROF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

PROFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsglobenewswire.com·22h ago·Neutral

    Profound Medical Announces Management Change TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the promotion of Matthew Sobczyk from Corporate Controller to Interim Chief Financial Officer, effective immediately. Mr. Sobczyk, who first joined Profound in 2020, succeeds Rashed Dewan, who has stepp…

    View source ↗